Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false2023-04-01falseNo description of principal activity11truefalse 12741046 2023-04-01 2024-03-31 12741046 2022-04-01 2023-03-31 12741046 2024-03-31 12741046 2023-03-31 12741046 2022-04-01 12741046 c:Director1 2023-04-01 2024-03-31 12741046 d:MotorVehicles 2023-04-01 2024-03-31 12741046 d:MotorVehicles 2024-03-31 12741046 d:MotorVehicles 2023-03-31 12741046 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 12741046 d:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 12741046 d:PatentsTrademarksLicencesConcessionsSimilar 2023-03-31 12741046 d:CurrentFinancialInstruments 2024-03-31 12741046 d:CurrentFinancialInstruments 2023-03-31 12741046 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 12741046 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 12741046 d:ShareCapital 2023-04-01 2024-03-31 12741046 d:ShareCapital 2024-03-31 12741046 d:ShareCapital 2022-04-01 2023-03-31 12741046 d:ShareCapital 2023-03-31 12741046 d:ShareCapital 2022-04-01 12741046 d:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 12741046 d:RetainedEarningsAccumulatedLosses 2024-03-31 12741046 d:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 12741046 d:RetainedEarningsAccumulatedLosses 2023-03-31 12741046 d:RetainedEarningsAccumulatedLosses 2022-04-01 12741046 c:FRS102 2023-04-01 2024-03-31 12741046 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 12741046 c:FullAccounts 2023-04-01 2024-03-31 12741046 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12741046 2 2023-04-01 2024-03-31 12741046 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2023-04-01 2024-03-31 12741046 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 12741046









BIO-VENT SYSTEMS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
BIO-VENT SYSTEMS LIMITED
REGISTERED NUMBER: 12741046

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
2,309
4,421

Tangible assets
 5 
21,750
-

  
24,059
4,421

Current assets
  

Stocks
 6 
176,885
226,284

Debtors: amounts falling due within one year
 7 
152,371
56,886

Cash at bank and in hand
 8 
222,962
-

  
552,218
283,170

Creditors: amounts falling due within one year
 9 
(485,605)
(305,845)

Net current assets/(liabilities)
  
 
 
66,613
 
 
(22,675)

Total assets less current liabilities
  
90,672
(18,254)

  

Net assets/(liabilities)
  
90,672
(18,254)


Capital and reserves
  

Called up share capital 
  
100
1

Profit and loss account
  
90,572
(18,255)

  
90,672
(18,254)


Page 1

 
BIO-VENT SYSTEMS LIMITED
REGISTERED NUMBER: 12741046
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 November 2024.




L R Mooney
Director

The notes on pages 5 to 9 form part of these financial statements.
Page 2

 
BIO-VENT SYSTEMS LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2024


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 April 2023
1
(18,255)
(18,254)


Comprehensive income for the year

Profit for the year

-
108,827
108,827


Other comprehensive income for the year
-
-
-


Total comprehensive income for the year
-
108,827
108,827


Contributions by and distributions to owners

Shares issued during the year
99
-
99


Total transactions with owners
99
-
99


At 31 March 2024
100
90,572
90,672


The notes on pages 5 to 9 form part of these financial statements.
Page 3

 
BIO-VENT SYSTEMS LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 April 2022
1
(8,611)
(8,610)


Comprehensive income for the year

Loss for the year

-
(9,644)
(9,644)


Other comprehensive income for the year
-
-
-


Total comprehensive income for the year
-
(9,644)
(9,644)


Total transactions with owners
-
-
-


At 31 March 2023
1
(18,255)
(18,254)


The notes on pages 5 to 9 form part of these financial statements.
Page 4

 
BIO-VENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Bio-Vent Systems Limited is a private company incorporated in England.
The company's registered office is 56 West Street, Stratford-upon-Avon, Warwickshire CV37 6DR.
These financial statements are presented in £ Sterling which is the functional currency of the company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 5

 
BIO-VENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 6

 
BIO-VENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including the director, during the year was as follows:


        2024
        2023
            No.
            No.







1
1


4.


Intangible assets




Intanagible assets

£



Cost


At 1 April 2023
8,450



At 31 March 2024

8,450



Amortisation


At 1 April 2023
4,029


Charge for the year on owned assets
2,112



At 31 March 2024

6,141



Net book value



At 31 March 2024
2,309



At 31 March 2023
4,421



Page 7

 
BIO-VENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Tangible fixed assets





Motor vehicles

£



Cost or valuation


Additions
29,000



At 31 March 2024

29,000



Depreciation


Charge for the year on owned assets
7,250



At 31 March 2024

7,250



Net book value



At 31 March 2024
21,750



At 31 March 2023
-


6.


Stocks

2024
2023
£
£

Raw materials and consumables
176,885
226,284

176,885
226,284



7.


Debtors

2024
2023
£
£


Trade debtors
111,372
46,673

Amounts owed by group undertakings
15,999
-

Other debtors
25,000
10,213

152,371
56,886


Page 8

 
BIO-VENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
222,962
-

Less: bank overdrafts
-
(30,769)

222,962
(30,769)



9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank overdrafts
-
30,769

Trade creditors
35,955
103,952

Amounts owed to group undertakings
373,923
169,924

Corporation tax
37,656
-

Other taxation and social security
36,871
-

Other creditors
1,200
1,200

485,605
305,845



10.


Controlling party

The controlling party is Leadar Limited.

 
Page 9